Monitoring of radiotherapy results using 3DCRT technique for local prostate cancer with PSA
Objectives
Study of the PSA changes after radiotherapy for local prostate cancer, using 3DCRT technique and evaluating these changes in relation to disease progression.
Patients and Methods
Between 1.6.2008 and 1.6.2010, a total of 135 patients were treated with Three Dimensional Conformal Radiation Therapy (3DCRT) for clinical stages T1-T3 Adenocarcinoma of the prostate.
The median age was 67 years (50-83), 10% had family history. 81% were smokers. The median PSA level was17.5 ng/ml (3.1-95). 32% were T2a and 50% T2b. The median Gleason score was 6 (3-7). 34% received the treatment after radical surgery for biochemical relapse and 64% as primary treatment.
60% received 66-70 Gy and 40% received 72-76 Gy. Patients were followed with PSA 3 monthly for 24 months. The median follow up was 12 months.
39 patients didn’t follow and therefore cancelled from the study. Only 96 patients ended the treatment and the follow up